Frencken Group's PATMI up 9.1% to $29.8m in 9M
Revenue from its semiconductor, medical segments drove this increase.
Frencken Group Limited registered a $29.8m profit after tax and minority interests (PATMI) in the first nine months of 2025 (9M2025), an increase of 9.1% year on year.
The firm cited higher revenue from its semiconductor and medical segments for the increase, it said in its financial statements.
In Q32025, meanwhile, Frencken’s semiconductor segment revenue increased 8.1% YoY to $99.1m, driven mainly by higher sales from its Asia operations that saw a broader product portfolio and a recovery in demand in the semiconductor equipment sector.
Its medical segment’s revenue improved 6.2% in Q3 to $31.7m due mainly to increased customer orders in Asia.
Frencken’s industrial automation segment’s revenue increased 51.1% YoY to $13.5m in Q3, driven by increased orders from its key customer in data storage solutions.
Its analytical life sciences segment’s revenue declined 8.3% YoY to $41m in Q3, attributed to lower customer demand in Europe.